inSoma Bio
Durham, NC · Biotechnology · 9 employees
inSoma Bio is a Duke University spinout and YC-backed company striving to build breast implants, personalized lumpectomy molds, and repair other soft tissue defects using a person’s own tissue without the need for major reconstructive surgery. We have developed an injectable gel that allows plastic surgeons to reliably build new tissue using a patient’s own liposuctioned fat without the need for s
Funding history
- Series seed — $2.7M — Jan 2026
- Series seed — $1.9M — Oct 2025
- Series seed — $2.7M — May 2024
- Series seed — $2.1M — Jun 2023
- Series seed — $1.1M — May 2023
Recent signals
- Jan 22, 2026: Raised $2.7M in Series seed
- Oct 20, 2025: Raised $1.9M in Series seed
- May 06, 2024: Raised $2.7M in Series seed
- Jun 29, 2023: Raised $2.1M in Series seed
- May 01, 2023: Raised $1.1M in Series seed
- Dec 01, 2020: Raised $1.3M in Series seed
- Nov 09, 2020: Raised $1.2M
- Oct 26, 2020: Raised $385K
See plans & pricing → Track inSoma Bio’s funding, hiring, and signals — with verified contacts — on Fundz.